These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 2878801

  • 1. [Anticholinergics during neuroleptic treatment. Value and withdrawal].
    Betermiez P, Delahousse J, Pedinielli JL.
    Encephale; 1986; 12(4):169-74. PubMed ID: 2878801
    [Abstract] [Full Text] [Related]

  • 2. [Antiparkinson drugs in neuroleptic treatment: comparative study of progressive and abrupt withdrawal].
    Ben Hadj Ali B, Dogui M, Ben Ammou S, Lôo H.
    Encephale; 1995; 21(3):209-15. PubMed ID: 7649071
    [Abstract] [Full Text] [Related]

  • 3. [Rhabdomyolysis in neuroleptic therapy: an abortive malignant neuroleptic syndrome?].
    Peschel O, Kurtz G, Müller-Felber W, Modell S.
    Nervenarzt; 1994 Oct; 65(10):718-21. PubMed ID: 7808573
    [Abstract] [Full Text] [Related]

  • 4. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P, Bret MC, Queuille E.
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [Abstract] [Full Text] [Related]

  • 5. Why is it so difficult to stop psychiatric drug treatment? It may be nothing to do with the original problem.
    Moncrieff J.
    Med Hypotheses; 2006 Apr; 67(3):517-23. PubMed ID: 16632226
    [Abstract] [Full Text] [Related]

  • 6. Ethosuximide and tremor in Parkinson's disease: a pilot study.
    Pourcher E, Gomez-Mancilla B, Bédard PJ.
    Mov Disord; 1992 Apr; 7(2):132-6. PubMed ID: 1350060
    [Abstract] [Full Text] [Related]

  • 7. Risk factors for drug-induced parkinsonism in tardive dyskinesia patients.
    Hansen TE, Brown WL, Weigel RM, Casey DE.
    J Clin Psychiatry; 1988 Apr; 49(4):139-41. PubMed ID: 2895762
    [Abstract] [Full Text] [Related]

  • 8. Absence of neuroleptic-induced parkinsonism in psychotic patients receiving adjunctive electroconvulsive therapy.
    Mukherjee S, Debsikdar V.
    Convuls Ther; 1994 Mar; 10(1):53-8. PubMed ID: 7914462
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of maintenance use of anticholinergic agents.
    Double DB, Warren GC, Evans M, Rowlands RP.
    Acta Psychiatr Scand; 1993 Nov; 88(5):381-4. PubMed ID: 7905226
    [Abstract] [Full Text] [Related]

  • 10. [Clinical characteristics of drug induced parkinsonism in psychotic patients].
    Giroud-Benítez JL, López-Suárez RM, Méndez-Chávez A, Vistorte-Pupo A, González-Torres R, López-Jaén I, Pradere-Pensado JC, Enriquez Lescano Gort L, Paz-Sendin L.
    Rev Neurol; 1993 Nov; 33(11):1095-7. PubMed ID: 11785039
    [No Abstract] [Full Text] [Related]

  • 11. Clozapine as a diagnostic tool for a psychotic parkinsonian patient.
    Frye MA, Wirshing WC, Ames D.
    J Clin Psychopharmacol; 1993 Oct; 13(5):359-60. PubMed ID: 7901246
    [No Abstract] [Full Text] [Related]

  • 12. Abuse potential of anticholinergics.
    Dose M, Tempel HD.
    Pharmacopsychiatry; 2000 Sep; 33 Suppl 1():43-6. PubMed ID: 11072764
    [Abstract] [Full Text] [Related]

  • 13. [Neuroleptic-induced palilalia. A currently undescribed side effect].
    García C.
    Nervenarzt; 1990 Nov; 61(11):676-83. PubMed ID: 1981250
    [No Abstract] [Full Text] [Related]

  • 14. Oculogyric crisis with exacerbation of psychosis: Possible mechanism and clinical implications.
    Thomas N, Sankar SS, Braganza D, Jayakrishnan S.
    Neurosci Lett; 2009 Feb 13; 451(1):50-1. PubMed ID: 19121367
    [Abstract] [Full Text] [Related]

  • 15. Discontinuation of neuroleptics in community-dwelling individuals with mental retardation and mental illness.
    Pary RJ.
    Am J Ment Retard; 1995 Sep 13; 100(2):207-12. PubMed ID: 8527116
    [Abstract] [Full Text] [Related]

  • 16. Seborrheic dermatitis: a newly reported side effect of neuroleptics.
    Binder RL, Jonelis FJ.
    J Clin Psychiatry; 1984 Mar 13; 45(3):125-6. PubMed ID: 6142036
    [Abstract] [Full Text] [Related]

  • 17. Neuroleptic-valproic acid combination in treatment of psychotic symptoms: a three-case report.
    Wassef A, Watson DJ, Morrison P, Bryant S, Flack J.
    J Clin Psychopharmacol; 1989 Feb 13; 9(1):45-8. PubMed ID: 2565347
    [Abstract] [Full Text] [Related]

  • 18. [Are the antipsychotic and side-effects of neuroleptics imperfectly known?].
    Schulz P.
    Biomed Pharmacother; 1987 Feb 13; 41(1):31-3. PubMed ID: 2886159
    [Abstract] [Full Text] [Related]

  • 19. Neuroleptic dose and the need for prophylactic anticholinergic drugs.
    McEvoy JP.
    J Clin Psychiatry; 1986 Dec 13; 47(12):611. PubMed ID: 2877977
    [No Abstract] [Full Text] [Related]

  • 20. Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia.
    Casey DE.
    Psychiatr Clin North Am; 1993 Sep 13; 16(3):589-610. PubMed ID: 8105453
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.